Data manager Ratna Jyothi Kommaraju's automation frameworks to handle 3 million biosamples and cut delays by 75% – a benchmark India’s clinical trial industry now looks to follow.

For cell therapy manufacturers such as Kite Pharma where every product is made for a single patient, labeling becomes a ...

In a sector where delays can compromise product stability and patient safety, air cargo has assumed a pivotal role in ...

Distilling that complexity into a handful of trends has been no small task. What follows is not a definitive forecast, but ...

With the acceptance of international GMP standards and duty-free certainty for key APIs, India is poised to strengthen its ...

The past year marked a period of sustained momentum for India’s healthcare and  pharmaceutical sector, supported by rising ...

Temperature Controlled Package for Pharmaceutical Market Size The global Temperature Controlled Package for Pharmaceutical ...

Niraj Patel is a visionary quality leader who uses digital transformation and strategic compliance to drive pharmaceutical ...

Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for investigational therapy pumitamig (BNT327/BMS986545) plus ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's offering.